Study Finds Hospitals Reduce Pediatric Patient Length of Stay by 25% by Deploying Etiometry Risk Analytics
News and Press Releases
Results of a Multi-Center, Retrospective Cohort Analysis of All Neonates Admitted to the CICU at Boston Children’s Hospital and the Hospital for Sick Children, Toronto
BOSTON, December 19, 2017—Etiometry, a pioneering leader in next-generation patient monitoring, announced today that a study presented in the American Heart Association (AHA) Scientific Sessions 2017 demonstrates the capability of the Etiometry Platform to significantly reduce hospitals intensive care unit costs.
The Impact of a Real-Time Physiologic Data Analytic Index on Length of Stay in Neonates Following Surgery for Congenital Heart Disease abstract presented results from a retrospective study conducted in the first two hospitals that adopted Etiometry’s Inadequate Delivery of Oxygen (IDO2) Index. The study was co-authored by: Dr. Josh Salvin, Boston Children’s Hospital; Dr. Peter Laussen MBBS FCICM, The Hospital for Sick Children, Toronto; and Dr. Dimitar Baronov, PhD, Etiometry’s CTO. It demonstrates a statistically significant 25% reduction of length of stay (LOS) for the neonates admitted for cardiac intensive care in the two hospitals.
According to Etiometry’s COO Evan Butler, “There is a wide expectation in the clinical community that impactful information technology and actionable data analytics should bring much-needed reduction in hospital costs and improvement in patient outcomes. We are proud to see our Etiometry Platform leading the way in proving these expectations by demonstrating measurable positive impact in an especially vulnerable patient population.”
The Etiometry Platform consists of three software components: T3 Data Aggregation & Visualization, Risk Analytics Algorithms, and Quality Improvement System. They are integrated to support clinical use cases, such as meaningful workflow integration and streamlined measurement of care impact. For more information, send an email to info@etiometry.com and request the Etiometry ROI whitepaper.About Etiometry
Etiometry Inc. is the leader in clinical decision-support software for the intensive care environment. Our technologies provide valuable clinical insight and analysis to support early recognition of subtle changes in patient condition to avoid complications and speed recovery. Etiometry is committed to improving patient outcomes, increasing clinical efficiency, and lowering costs of care through the more effective use of all available data.
For more information, visit www.etiometry.com.
We’d love to hear from you
Whether you’re curious about how Etiometry can help support your team, the platform’s latest outcomes data or a demo – we’re ready to answer your questions.
Contact UsRelated
Hamilton Medical, Inc. and Etiometry Partner to Advance Data-Driven Respiratory Care in the ICU
Collaboration combines advanced ventilation technology with AI-driven clinical intelligence to support more proactive, data-driven respiratory management BOSTON, Mass. – Sep. 10, 2026 – Hamilton Medical, Inc. and Etiometry today announced a US partnership to bring AI-driven, data-supported respiratory intelligence to intensive care teams managing mechanically ventilated patients. The collaboration combines Hamilton Medical’s advanced ventilation technology and […]
The Documentation Gap Nobody Talks About — And What It’s Costing Your ICU
Every ICU has a documentation problem. Most don’t know the full scope of it. Clinical events happen continuously in high-acuity care — hemodynamic shifts, ventilatory changes, transient complications that resolve before the next chart entry. Clinicians respond to them. They manage through them. And then, in the relentless pace of the ICU, those events may […]